We provide our patients with the best treatments.
We strive to optimise both the quality and quantity of life of our oncology patients.
Through our Medical Oncology team, we develop a deep understanding of our clients condition and strive to offer a tailored treatment plan that optimises the outcome for our patients and their owners.
Your client’s first consultation with us will last at least an hour, during which we will explain the merits of further investigation where necessary, elaborate on the implications of the diagnosis for their pet, discuss different aspects of therapy, and answer all of their questions. We find the resultant tailored investigation and treatment plans motivate and satisfy our clients.
Many clients opt to have their pet’s care shared between their local veterinarian and the AHT, visiting us to avail of our specialist staff and facilities for any procedures or treatments you would like us to take care of. Some novel treatments do require visits to the AHT such as immunotherapy for melanomas, plesiotherapy for superficial tumours, and receptor tyrosine kinase inhibitor therapy for several tumour types.
What we offer:
- Diagnostics and staging including advanced imaging for surgical and radiotherapy planning, supported by our specialists in pathology, imaging, anaesthesia and surgery
- State of the art surgery, chemotherapy and radiotherapy
- Novel immunotherapies such as vaccinal treatment of oral malignant melanomas
- Emerging targeted medical therapies such as receptor tyrosine kinase inhibitors
- We are the only centre in the UK to offer Strontium plesiotherapy for superficial tumours of the eyelid, nasal planum and other locations
- We work closely with our specialist colleagues in the AHT’s other departments, particularly internal medicine and neurology, taking care of internal referrals when a neoplastic diagnosis is made
- Please feel free to contact us by any of the above methods to discuss a case or arrange a prompt referral. We do not discuss specific cases with pet owners without your expressed consent
- We also welcome visiting veterinarians if you would like spend some time with us on clinics
- Prompt communication both with you and the client.
Through our Radiation Oncology team, we are committed to offering the latest technologies in this field changing the prognosis and hope for our patients.
What we offer:
- A Radiation Therapy Team with a boarded Radiation Oncology Specialist, a physicist, a dosimetrist, a therapeutic radiographer and a Radiation therapy nurse
- An Integrated Oncology Department with a multidisciplinary team including Oncology consultation, advanced imaging, collaboration with medical Oncologists, soft tissue surgeons, internists, Neurologists and our Pathology department
- Research collaboration with the Animal Health Trust veterinary research units: The Animal Health Trust Cancer Group which includes Pathology, Genetics, Immunology, stem cell researchers and clinicians. Together, we are combining our efforts to bring new therapies that are tailored to each individual cancer
- Translational Research Collaborative research with prestigious Human Cancer Institutions. Our small animal patients are benefiting from the most advanced technologies offered to human patients as we keep developing and sharing new practises.
- State-of-the-art Radiation technologies
- External beam treatment
- Linac Varian 23IX, photons, electrons, energy capacity
- Fine resolution120 MLC to accurately target treatment
- Image guidance allows precise patient positioning
- Specific radiation immobilization devices (mask, grid, bite block) for enhanced set-up processes
- Modern computerised treatment plan software (Eclipse, Brachyvision)
- Integrated Imaging department: MRI 1.5 T; 16 slices CT
- HDR: High Dose Rate Brachytherapy
- The only facility to offer HDR in the UK
- HDR is a radiation technique allowing targeted delivery of radiation inside the tumour with minimal spread to other the critical structures
- It can be used
- as a unique radiation technique for certain conditions ie cat fibrosarcoma
- as possible radiation boost for recurrent tumours, for cancers with biological aggressive behaviour and as a complement to external beam therapy
- for tumours at risk of stenosis such as urethral carcinoma
- We offer Strontium 90 applications for superficial tumours ie skin, eyelid, nasal planum tumours such as squamous cell carcinoma or mast cell tumours.